Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic equivalence study of tacrolimus 0.1% ointment versus Protopic and vehicle in adult atopic dermatitis
2011-006236-23Phase 3Completed
- Sponsor
- Accord Healthcare
- Start
- Apr 2012
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Envarsus XR, tacrolimus in atopic dermatitis (AD), sponsored by Accord Healthcare. Started Apr 2012; status: completed.
02
Drugs
Envarsus XRtacrolimus
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2011-006236-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-006236-23.